DCGI approves indigenous mRNA COVID jab for emergency use in 18 years and above; Kovovax for 7-11 years

The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenous drug against COVID-19…

Government panel recommends emergency approval of SII’s Kovovax for children aged 7-11

New Delhi: The Subject Expert Committee (SEC) on COVID-19, an expert panel of the Central Drugs…

Government panel recommends emergency approval of Kovovax for age group 12-17

new Delhi: An expert committee of the country’s Central Drugs Authority on Friday recommended emergency use…

Expert panel approves Bharat Biotech’s Covaxin jab for children aged 12 years and above

Image Source: PTI Expert panel approves Bharat Biotech’s Covaxin jab for 12-18 year olds Highlight Bharat…

Sputnik Light Coronavirus Vaccine | COVID Vaccine Sputnik Lite Receives Phase III Trial Approval: How is Sputnik Lite Different from Sputnik V?

Sputnik Lite is a new, different vaccine, developed by Russia’s Gamalya Institute in collaboration with RDIF.…

Nagpur: DGGI arrests four for carrying on fraudulent business by availing input tax credit of Rs 10.79 crore. Nagpur News – Times of India

Nagpur: Nagpur Regional Unit of Directorate General GST Intelligence The (DGGI) has arrested four persons for…

Assam: Sputnik v Preferred jab for short intervals between doses. Guwahati News – Times of India

Guwahati: satellite v vaccine, Produced by Russia, has already become a popular shot among the beneficiaries…